Back to Journals » Therapeutics and Clinical Risk Management » Volume 15

Review

Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapy

         
Total article views   Abstract views HTML views PDF downloads Totals
7,639 Dovepress* 3,603 1,471+ 1,502 5,074
PubMed Central* 0 2,565 361 2,565
Totals 3,603 4,036 1,863 7,639
*Since 11 April 2019
+Since July 2016

View citations on PubMed Central and Google Scholar